世界の胃食道逆流症（GERD）治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2493 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、胃食道逆流症（GERD）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（制酸剤、運動促進薬、H2受容体遮断薬、プロトンポンプ阻害薬（PPI））、用途別市場規模（胸焼け、胃酸逆流症）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・胃食道逆流症（GERD）治療の市場動向 ・企業の競争状況、市場シェア ・胃食道逆流症（GERD）治療の種類別市場規模（制酸剤、運動促進薬、H2受容体遮断薬、プロトンポンプ阻害薬（PPI）） ・胃食道逆流症（GERD）治療の用途別市場規模（胸焼け、胃酸逆流症） ・胃食道逆流症（GERD）治療の北米市場規模2016-2027（アメリカ、カナダ） ・胃食道逆流症（GERD）治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・胃食道逆流症（GERD）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・胃食道逆流症（GERD）治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・胃食道逆流症（GERD）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AstraZeneca、Eisai、GSK、Takeda、Johnson & Johnson） ・結論

Market Analysis and Insights: Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market
The global Gastroesophageal Reflux Disease (GERD) Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gastroesophageal Reflux Disease (GERD) Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gastroesophageal Reflux Disease (GERD) Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gastroesophageal Reflux Disease (GERD) Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gastroesophageal Reflux Disease (GERD) Therapeutics market.

Global Gastroesophageal Reflux Disease (GERD) Therapeutics Scope and Market Size
Gastroesophageal Reflux Disease (GERD) Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gastroesophageal Reflux Disease (GERD) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antacids
Pro-kinetic agents
H2 Receptor Blockers
Proton Pump Inhibitors (PPIs)

Segment by Application
Heartburn
Acid reflux disorders

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
Eisai
GSK
Takeda
Johnson & Johnson

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antacids
1.2.3 Pro-kinetic agents
1.2.4 H2 Receptor Blockers
1.2.5 Proton Pump Inhibitors (PPIs)
1.3 Market by Application
1.3.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Heartburn
1.3.3 Acid reflux disorders
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Perspective (2016-2027)
2.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Growth Trends by Regions
2.2.1 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Industry Dynamic
2.3.1 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Trends
2.3.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Drivers
2.3.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Challenges
2.3.4 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Players by Revenue
3.1.1 Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue
3.4 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Concentration Ratio
3.4.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue in 2020
3.5 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players Head office and Area Served
3.6 Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Product Solution and Service
3.7 Date of Enter into Gastroesophageal Reflux Disease (GERD) Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gastroesophageal Reflux Disease (GERD) Therapeutics Breakdown Data by Type
4.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Type (2022-2027)

5 Gastroesophageal Reflux Disease (GERD) Therapeutics Breakdown Data by Application
5.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2016-2027)
6.2 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
6.2.1 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2016-2027)
6.3 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application
6.3.1 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2016-2027)
6.4 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country
6.4.1 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2016-2027)
7.2 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
7.2.1 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2016-2027)
7.3 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application
7.3.1 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2016-2027)
7.4 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country
7.4.1 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
8.2.1 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application
8.3.1 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region
8.4.1 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2016-2027)
9.2 Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
9.2.1 Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application
9.3.1 Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country
9.4.1 Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
10.2.1 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application
10.3.1 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country
10.4.1 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
11.1.4 AstraZeneca Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Eisai
11.2.1 Eisai Company Details
11.2.2 Eisai Business Overview
11.2.3 Eisai Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
11.2.4 Eisai Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2016-2021)
11.2.5 Eisai Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
11.3.4 GSK Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2016-2021)
11.3.5 GSK Recent Development
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
11.4.4 Takeda Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2016-2021)
11.4.5 Takeda Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
11.5.4 Johnson & Johnson Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antacids
Table 3. Key Players of Pro-kinetic agents
Table 4. Key Players of H2 Receptor Blockers
Table 5. Key Players of Proton Pump Inhibitors (PPIs)
Table 6. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Regions (2022-2027)
Table 12. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Trends
Table 13. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Drivers
Table 14. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Challenges
Table 15. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Restraints
Table 16. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics as of 2020)
Table 19. Ranking of Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Product Solution and Service
Table 23. Date of Enter into Gastroesophageal Reflux Disease (GERD) Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. AstraZeneca Company Details
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Gastroesophageal Reflux Disease (GERD) Therapeutics Product
Table 66. AstraZeneca Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2016-2021) & (US$ Million)
Table 67. AstraZeneca Recent Development
Table 68. Eisai Company Details
Table 69. Eisai Business Overview
Table 70. Eisai Gastroesophageal Reflux Disease (GERD) Therapeutics Product
Table 71. Eisai Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Eisai Recent Development
Table 73. GSK Company Details
Table 74. GSK Business Overview
Table 75. GSK Gastroesophageal Reflux Disease (GERD) Therapeutics Product
Table 76. GSK Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2016-2021) & (US$ Million)
Table 77. GSK Recent Development
Table 78. Takeda Company Details
Table 79. Takeda Business Overview
Table 80. Takeda Gastroesophageal Reflux Disease (GERD) Therapeutics Product
Table 81. Takeda Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2016-2021) & (US$ Million)
Table 82. Takeda Recent Development
Table 83. Johnson & Johnson Company Details
Table 84. Johnson & Johnson Business Overview
Table 85. Johnson & Johnson Gastroesophageal Reflux Disease (GERD) Therapeutics Product
Table 86. Johnson & Johnson Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Johnson & Johnson Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Antacids Features
Figure 3. Pro-kinetic agents Features
Figure 4. H2 Receptor Blockers Features
Figure 5. Proton Pump Inhibitors (PPIs) Features
Figure 6. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Heartburn Case Studies
Figure 8. Acid reflux disorders Case Studies
Figure 9. Gastroesophageal Reflux Disease (GERD) Therapeutics Report Years Considered
Figure 10. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Players in 2020
Figure 15. Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue in 2020
Figure 17. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Region (2016-2027)
Figure 39. China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. AstraZeneca Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2016-2021)
Figure 59. Eisai Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2016-2021)
Figure 60. GSK Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2016-2021)
Figure 61. Takeda Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

---